Singular Genomics Sys: Q4 Earnings Insights
Portfolio Pulse from Benzinga Insights
Singular Genomics Systems (NASDAQ:OMIC) reported Q4 earnings, beating estimates with an EPS of $-0.32 against an expected $-0.34 and saw a revenue increase of $316 thousand year-over-year. The company has a history of surpassing EPS estimates, which previously led to a 7% stock price increase the following day.
March 18, 2024 | 8:40 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Singular Genomics Systems reported better than expected Q4 earnings with an EPS of $-0.32 and a year-over-year revenue increase of $316 thousand.
Singular Genomics Systems' positive earnings report, beating estimates and showing revenue growth, typically signals a positive short-term impact on the stock price. Historical data supports this, as past earnings beats were followed by stock price increases.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100